Archive for the ‘vaccines’ Category

The Vaccine Debate – Top Government Expert States Vaccines CAN Cause Autism in Some Children

UPDATE Nov. 2024:

Over 300 pages of evidence from the CDC shows that ‘vaccines’ cause autism. Investigative reporter Sharyl Attkisson exposes that the “bulk of credible science finds ‘vaccines’ ‘can and do’ cause autism.” See 76 Studies and Comprehensive Resource on vaccines.  Dr. Andrew Wakefield was right all along despite his seminole paper being retracted 12 years after the fact without any violations of guidelines.  The Cabal systematically destroyed his reputation for reporting his findings.  He later produced Protocol 7 which details Merck’s MMR fraud.  This is what they do to dissenters – merciless, ad hominem attacks.

http://fullmeasure.news/news/full-episodes/full-measure-january-6-2019    Video in Link.  Approx. 23 Min.

Full Measure With Sharyl Attkisson

Sunday, Jan. 6, 2019

By Full Measure Staff

Transcript of Video:

Today we investigate one of the biggest medical controversies of our time: vaccines. There’s little dispute about this much– vaccines save many lives, and rarely, they injure or kill. A special federal vaccine court has paid out billions for injuries from brain damage to death. But not for the form of brain injury we call autism. Now—we have remarkable new information: a respected pro-vaccine medical expert used by the federal government to debunk the vaccine-autism link, says vaccines can cause autism after all. He claims he told that to government officials long ago, but they kept it secret.

Yates Hazlehurst was born February 11, 2000. Everything was normal, according to his medical records, until he suffered a severe reaction to vaccinations.

Rolf Hazlehurst: And at first, I didn’t believe it. I did not think that, I did not believe that vaccines could cause autism. I didn’t believe it.

But there’s a hard reality for Yates. The trademark brain disease, pain and inability to communicate that’s common with severe autism.

In 2007, Yates’ father sued over his son’s injuries in the little known Federal Vaccine court. It was one of more than 5000 vaccine autism claims.

Congress created vaccine court in 1988, in consultation with the pharmaceutical industry. In the special court, vaccine makers don’t defend their products—the federal government does it for them, using lawyers from the Justice Department. Money for victims comes from us, not the pharmaceutical industry, through patient fees added onto every vaccine given.

Denise Vowell: Our hearings are all closed to the public. And that’s statutory.

In 2007, Yates’ case and nearly all the other vaccine autism claims lost. The decision was based largely on the expert opinion of this man, Dr. Andrew Zimmerman, a world-renowned pediatric neurologist shown here at a lecture.

Dr. Zimmerman was the government’s top expert witness and had testified that vaccines didn’t cause autism. The debate was declared over.

But now Dr. Zimmerman has provided remarkable new information. He claims that during the vaccine hearings all those years ago, he privately told government lawyers that vaccines can, and did cause autism in some children. That turnabout from the government’s own chief medical expert stood to change everything about the vaccine-autism debate.

If the public were to find out.

Hazlehurst: And he has come forward and explained how he told the United States government vaccines can cause autism in a certain subset of children and United States government, the Department of Justice suppressed his true opinions.

Hazlehurst discovered that later when Dr. Zimmerman evaluated Yates as a teenager. That’s when he partnered with vaccine safety advocate Robert F. Kennedy, Junior—who has a voice condition.

Kennedy: This was one of the most consequential frauds, arguably in human history.

Kennedy was instrumental in convincing Dr. Zimmerman to document his remarkable claim of the government covering up his true expert opinion on vaccines and autism.

Dr. Zimmerman declined our interview request and referred us to his sworn affidavit. It says: On June 15, 2007, he took aside the Department of Justice—or DOJ lawyers he worked for defending vaccines in vaccine court. He told them that he’d discovered

“exceptions in which vaccinations could cause autism.” “I explained that in a subset of children, vaccine induced fever and immune stimulation did cause regressive brain disease with features of autism spectrum disorder.”

Kennedy: This panicked the two DOJ attorneys and they immediately fired Zimmerman. That was on a Friday and over the weekend they called Zimmerman and said his services would no longer be needed. They wanted to silence him.

Days after the Department of Justice lawyers fired Dr. Zimmerman as their expert witness, he alleges, they went on to misrepresent his opinion to continue to debunk autism claims. Records show that on June 18, 2007, a DOJ attorney Dr. Zimmerman spoke to told vaccine court,

“We know [Dr. Zimmerman’s] views on the issue…There is no scientific basis for a connection” between vaccines and autism.

Dr. Zimmerman now calls that “highly misleading.”

The former DOJ lawyer didn’t return our calls and emails. Kennedy has filed a fraud complaint with the Justice Department Inspector General, who told us they don’t “comment on investigations or potential investigations.”

Meantime, CDC—which promotes vaccines and monitors vaccine safety– never disclosed that the government’s own one-time medical expert concluded vaccines can cause autism – and to this day public health officials deny that’s the case.

Dr. Anne Schuchat: “Based on dozens of studies and everything I know as a physician and a scientist, there’s no link between autism and vaccines.”

CDC declined our interview request. In addition to filing a fraud complaint, Kennedy has delivered Dr. Zimmerman’s affidavit to leaders on Capitol Hill. But there he claims, is another key part of this story: roadblocks set up by the pharmaceutical industry—or PhRMA.

Kennedy: But everybody takes money from PhRMA so they’ve all been corrupted. And it’s almost impossible to get anything done on Capitol Hill.

Kennedy, a Democrat, isn’t the only one claiming vaccine industry money rules the day. We spoke to 11 current and former members of Congress and staff who claim they faced pressure, bullying or threats when they raised vaccine safety questions. Several of them agreed to appear on camera.

Burton: There’s no question in my mind whatsoever that the pharmaceutical industry had a great influence with people over at the CDC and FDA. There’s no question in my mind.

Republican Dan Burton—former Chairman of the House Oversight Committee—has an autistic grandson.

Burton: I am not against vaccinations.

He pursued vaccine investigations in the early 2000s. Beth Clay was one of his staffers.

Clay: There was a lot of pressure from people on the Hill.

When you say people on the hill were exerting pressure, what kind of people? Colleagues?

Clay: Colleagues, there were pharmaceutical lobbyists. The pharmaceutical lobbyists had, you know, they are the same people that have been entrenched. They can walk into any office in Capitol Hill, and they’ll talk to staff, they’ll talk to members and they’ll encourage them to discourage, our investigation.

Sharyl: At the risk of stating the obvious why did they have that kind of access to members?

Clay: It’s money. And if you look at the donations over the last 20 years, the pharmaceutical industry, and Republican and Democrat, they’re nonpartisan. They put money everywhere.

Former Congressman, Dr. Dave Weldon, a Republican, says he got the message loud and clear.

Sharyl: If you would want to hold a hearing on an issue like vaccines and autism, your own leadership might fight you on that because of the financial influence, the pharmaceutical industry

Dave Weldon: They wouldn’t fight you. They’d kill it. It’s dead. They don’t even want to discuss it. It’s dead on arrival. If you, if you as an individual member want to take on the pharmaceutical industries. It’s forget it.

Sharyl: Can you describe an incident or just how it, how that would go?

Weldon: It would typically be in a hallway or the street and people would come up to you and say, “You know, you really need to, you know, back off on this. It could be, it could be bad for the community or bad for the country or bad for you.”

Weldon says he’s generally pro-vaccine, depending on the patient and the shot—and gives flu shots to adults. We asked him to review Dr. Zimmerman’s new affidavit.

Weldon: I found his affidavit and testimony through that affidavit to be consistent with my opinions. That some children can get an autism spectrum disorder from a vaccine.

Republican Bill Posey is a current member of Congress.

Rep. Bill Posey: I don’t have to tell you that industry is a very, very powerful industry. Matter of fact, I don’t know of anyone more powerful than that industry.

Posey says his own party leaders twice promised to hold hearings on the topic, only to scuttle them in the end.

Hazlehurst – who happens to be a criminal prosecutor– was scheduled to be a witness at one such Congressional hearing. Two weeks before the hearing in 2013, he briefed Congressional staff.

Hazlehurst: I presented at that Congressional briefing and I explained in that hearing, if I did to a criminal in a court of law what the United States Department of Justice did to vaccine injured children, I would be disbarred and I would be facing criminal charges. I think that scared the hell out of them.

The hearing was abruptly cancelled. Meantime, Dr. Zimmerman – the one-time expert used to debunk vaccine autism claims—now says several of his own patients got autism from vaccines. They include Yates Hazlehurst.

Today, with intensive treatment, Yates is doing better. His dad hopes the new testimony from a most unlikely source will get new attention.

Hazlehurst: A child that was unnecessarily sacrificed and hopefully some good, will come from his suffering.

The lobby group representing the pharmaceutical industry wouldn’t agree to an interview but told us they’re working with Congress and other stakeholders on the importance and safety of vaccines to support the health and safety of individuals and communities.

_________________

**Comment**

The plot against vaccines just keeps thickening.

Here you can see the ACIP vote “yes” for a new vaccine despite the lack of safety studies on the cumulative effects: https://madisonarealymesupportgroup.com/2018/09/08/acip-vote-yes-for-new-vaccine-despite-no-safety-studies-on-cumulative-effect-with-other-vaccines/  It’s all right here in bright purple crayon.

This is how brand new vaccines are approved to the pediatric immunization schedule. Basic dialogue before they voted:
Q: Is it dangerous to use this vaccine with other vaccines?
A: We have no data on that. Once approved, it will be given along with other vaccines but we have no clue whether that’s safe or not.

Somehow approving a new vaccine with no data on the accumulated cocktail effect is OK to them IF you put them in different limbs……scientifically, this is quite a head scratcher.

By nature, vaccines are systemic.

Q: Do we at least have any data from other countries that used this vaccine in combination with other vaccines?
A: Not to my knowledge.

Sounds good to me. Lets vote yes!

Only after they vote, one guy voices concern over 16 heart attack deaths in the safety trials.

Illogic at it’s best.

Perhaps it has something to do with money & power? https://thevaccinereaction.org/2018/09/global-vaccine-market-expected-to-reach-50-52-billion-by-2023/   The value of the vaccine market will reach $50.42 billion by 2023 from $36.45 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 6.7 percent, according to recently published report by private research firm MarketsandMarkets of India.1

https://madisonarealymesupportgroup.com/2018/08/24/financial-kickbacks-for-vaccinations-abusive-illegal-fraudulent/ “This brings us to the financial incentives to pediatricians offered by insurance companies for vaccinating our children. The Blue Cross Blue Shield health insurance document explaining these financial incentives can be found here: https://jeffreydachmd.com/wp-content/uploads/2018/08/Pediatricians-Receive-Financial-Incentives-Kickbacks-to-Vaccinate-Children-BCBS-2016-Booklet.pdf Pediatricians are raking in 40-80 thousand dollars a year from these kickback schemes.”

https://madisonarealymesupportgroup.com/2018/10/05/drug-companies-pay-fda-nih-to-fast-track-market-vaccines/

https://madisonarealymesupportgroup.com/2018/10/19/fda-official-uses-revolving-door-to-join-biotech-company-developing-mrna-vaccines/

Category:

Activism, Autism, vaccines

FDA Approves 6 in 1 Combo Vaccine for Babies

https://thevaccinereaction.org/2019/01/fda-approves-6-in-1-combo-vaccine-for-babies/

FDA Approves 6 in 1 Combo Vaccine for Babies

by Kate Raines
Published January 3, 2019

FDA Approves 6 in 1 Combo Vaccine for Babies

Story Highlights

  • On Dec. 21, 2018, the U.S. Food and Drug Administration (FDA) approved a new combination hexavalent vaccine (Vaxelis) that includes antigens for six diseases to be given in three doses to infants and children between six weeks and four years of age.
  • Manufacturers Sanofi Pasteur and Merck jointly developed Vaxelis, which combines diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenza type B vaccines into one shot, and the new combination vaccine is expected to be commercially available in the U.S. in 2020.
  • The FDA has only approved Vaxelis to be given to infants for the first three doses, usually given at two, four and six months, and children will have to get a separate dose of DTaP vaccine to complete the primary pertussis vaccine before age four.

On Dec. 21, 2018, the U.S. Food and Drug Administration (FDA) approved a new combination hexavalent vaccine (Vaxelis) that includes antigens for six different diseases: diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive haemophilus influenza type B.1   Vaccine manufacturers Sanofi Pasteur and Merck jointly developed Vaxelis, which is approved to be given in three doses to children between six weeks and four years of age but children will have to get a separate dose of DTaP vaccine to complete the primary pertussis vaccine series before age four. The new combination vaccine is expected to be commercially available in the U.S. in 2020.2

Sanofi provided the antigens for diphtheria, tetanus, pertussis, and poliomyelitis for Vaxelis production and Merck provided antigens for H. influenzae type b and hepatitis B.3 Vaxelis has been approved by government regulators in the European Union since 2016.4

Monovalent vaccines include only one antigen, while multivalent or polyvalent vaccines like Vaxelis include either more than one strain of a microorganism or more than one type of microorganism. Widely used multivalent vaccines include the live attenuated measles, mumps and rubella vaccine (MMR) and the inactivated diphtheria, tetanus and acellular pertussis vaccines (DTaP for children under age seven and Tdap for older children and adults). Separate vaccines for measles, mumps, rubella and pertussis are not available in the U.S., while tetanus and diphtheria vaccines are only available as a combination (DT or Td) vaccine.

Drawbacks of Combination Vaccines

Combination vaccines have been created by manufacturers to purportedly reduce the number of shots a child must receive to be in compliance with government recommended childhood vaccine schedules and to simplify ordering, transport and storage of vaccines.5

Drawbacks to the multivalent vaccines include a higher risk of pain and swelling at the injection site and, and for Merck’s MMRV (mumps, measles, rubella, varicella) vaccine in particular, a higher incidence of febrile seizures in children under age four.7   The product manufacturer package insert for the new hexavalent vaccine states that,

“Vaxelis is contraindicated in children with a history of severe allergic reaction to any of the ingredients of the vaccine, or to any “other diphtheria toxoid, tetanus toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine, hepatitis B vaccine, or H. influenzae type b vaccine.”

According to the Vaxelis product insert, contraindications include

“a history of encephalopathy (coma, decreased levels of consciousness, prolonged seizures) within 7 days of a previous dose of pertussis-containing vaccine, that is not attributable to another cause” and “a history of progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy until a treatment regimen has been established and the conditions has stabilized.”

Warnings and Precautions include temperature over 105F within 48 hours not attributable to another identifiable cause; collapse or shock-like state (hypotonic-hyporesponsive episode (HHS) within 48 hours; persistent, inconsolable crying lasting more than three hours within 48 hours; and seizures with or without fever within three days.

The product insert reports high rates of adverse reactions among children receiving the experimental hexavalent vaccine in clinical trials:

“Rates of adverse reactions varied by number of doses of Vaxelis received. The solicited adverse reactions 0-5 days following any dose were irritability (≥55 percent), crying (≥45 percent), injection site pain (≥44 percent), somnolence (≥40 percent), injection site erythema (≥25 percent), decreased appetite (≥23 percent), fever ≥38.0°C (≥19 percent), injection site swelling (≥18 percent), and vomiting (≥9 percent).”1

References:

1 Sanofi Pasteur. FDA Approves VAXELIS™, Sanofi and MSD’s Pediatric Hexavalent Combination Vaccine. Press Release Dec. 6, 2018.
2 Sheinin AG. FDA Approves New Children’s Vaccine. WebMD Dec. 28, 2018.
3 Hackett DW. Hexavalent Vaccine for Children Less Than 5 Years of Age Approved. Precision Vaccinations Dec. 27, 2018.
4 Vaxelis®, New Fully-liquid Paediatric Hexavalent Vaccine Approved in the European Union. Ciston PR Newswire Feb. 19, 2016.
5 Lee BY. How About 6 Vaccines In One? FDA Approves New Vaccine From Sanofi, Merck. Forbes Dec. 28, 2018.

__________________

**Comment**

http://www.greenmedinfo.com/blog/vaccine-bombshell-leaked-confidential-document-exposes-36-infants-dead-after-vacc?

In the above link, a confidential GlaxoSmithKline document revealed 36 infants died after another 6 in 1 shot called Infanrix Hexa.  It also caused 1,742 adverse reactions, including 503 which were serious.

Another drawback not mentioned is the inability to track adverse reactions to any one particular vaccine since they are all thrown together. Secondly, when you consider that each of these vaccines has their own set of adverse reactions, one can only imagine the combined effect upon immature immune systems.  

It’s sad that manufacturers are more concerned with convenience (ordering, transporting, and storage of vaccines) than with public health.  This is a problem.

With increasing rates of childhood autism, neurological issues, and the polio-like condition known as acute flaccid myelitis (AFM), you’d think there would be extra caution taken regarding childhood vaccines not less.  Yet, vaccine manufacturers and our government bullishly move forward despite increasing evidence of lack of vaccine safety studies and even proof of vaccine effectiveness.

Regarding AFM, the CDC has confirmed 158 cases in 36 states, and they’ve only been recording cases since 2014:  https://thevaccinereaction.org/2019/01/cdc-reports-182-confirmed-cases-of-afm/  AFM causes inflammation of the spinal cord.  As to cause, authorities bounce from a pathogen to an autoimmune syndrome (similarly to chronic Lyme).  It’s been compared to Guillain-Barré Syndrome (GBS), in which the immune system attacks healthy nerve cells.  Some believe AFM is caused by a virus.

Again, since there is an upsurge in AFM with cause unknown, prudence would err on the side of caution regarding vaccinations since retroviral contamination in vaccines has been discovered:  https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

https://madisonarealymesupportgroup.com/2018/03/01/vaccines-could-contribute-to-disease-epidemics-due-to-retrovirus-contamination/

https://madisonarealymesupportgroup.com/2018/12/09/vaccines-likely-infected-with-retroviruses-linked-to-chronic-disease/

https://madisonarealymesupportgroup.com/2018/06/23/the-role-of-retroviruses-in-chronic-illness-a-clinicians-perspective/  Retroviruses can be acquired (inhalation, blood-based products, physical contact) or the viruses already present in our DNA can be activated through influences such as a viral infection or chronic inflammation (Manghera and Douville, 2013).

For example, the Epstein Barr virus induces expression of the HERV-K envelope gene and the transactivation of MSRV, the Multiple Sclerosis retrovirus (Mameli et al, 2007; Sutkowski et al, 2001). Herpes simplex type-2 activates members of the HERV-W family. These and other mechanisms are likely responsible for the activation of HERVs seen in rheumatoid arthritis, SLE, Sjorgens disease, schizophrenia, autism, MS and cancer. Cell phone radiation has disabled many of our protective proteins (Fragopoulou et al, 2012) and so have many of the food-based toxins such as glyphosate (Seneff et al, 2017) and air-based inhalants (aluminium etc). An unintended source of retroviruses are some vaccines as reported in Frontiers in Microbiology in January 2011).

It’s all here in purple crayon yet isn’t making any mainstream news.

It is estimated that 6% of the U.S. population is harboring a retrovirus in their bodies that can develop into an acquired immune deficiency. This is not the well-known AIDS caused by HIV, but Acquired Immune Deficiency Syndrome (AIDS) associated with other retroviruses.

That’s 20 million Americans with a retrovirus that can be spread through inhalation, blood-based products, and physical contact.

Many are also including vaccines.  

A simple tick bite could be one trigger that ignites the sleeping retrovirus giant.

 

 

 

 

 

 

 

 

Category:

Activism, vaccines

Concerns About Valneva VLA15 Lyme Vaccine Trials

https://www.linkedin.com/pulse/many-100s-subjects-participating-valneva-vla15-lyme-luche-thayer/

Many 100s of Subjects Participating in Valneva VLA15 Lyme Vaccine Trials

Published on December 16, 2018

 

FRIENDS,

The OspA based LYMErix vaccine was problematic with 1000+ adverse reactions and ongoing severe complications. According to the US government, the LYMErix vaccine had many health risks and was quite ineffective. Nevertheless, the biotech company Valneva appears to be using a similar OspA-based technology for their VLA15 Lyme vaccine.

TO NOTE: On December 3, 2018, the US federal Tick Borne Diseases Working Group stated they would be addressing Lyme vaccine safety concerns in their 2020 Report to Congress. This 2020 Report to Congress coincides with the end of the most experimental and riskier phases of the VLA15 trials.

US GOVERNMENT MESSAGE ON LYMERIX

The Directorate of Technical Support of the Department of Labor’s (USDOL) Occupational Safety and Health Administration’s (OSHA) issues Hazard Information Bulletins in accordance with OSHA instruction CPL 2.65 to provide relevant information regarding unrecognized or misunderstood health hazards. Hazard Information Bulletins are initiated based on information provided by the field staff, studies, reports and concerns expressed by safety and health professionals, employers and the public. Bulletins are developed based on thorough evaluation of available facts in coordination with appropriate parties.

Excerpted from the USDOL/OSHA Hazard Information Bulletin [1] regarding the LYMErix Vaccine:

“Communications with the Vaccine Adverse Events Reporting System Hotline during September 1999 indicated some reports of adverse events relating to LYMErix have been made”

“Lyme disease vaccine does not protect all recipients against infection with B. burgdorferi (Lyme)”

“Consequently, vaccinated persons, as well as the unvaccinated, should continue to practice good prevention and personal protective measures to prevent tick bites, and they should seek medical attention for early diagnosis and treatment of suspected tickborne infections”

“The duration of protection with LYMErix is not known …”

“LYMErix is not recommended for certain groups of people [including] Pregnant Women, Persons with Immunodeficiency and Persons with Musculoskeletal Disease [such as] persons with diseases associated with joint swelling (including rheumatoid arthritis) or diffuse musculoskeletal pain”

“Safety and efficacy are unknown for persons with chronic joint or neurological illness related to Lyme disease and for persons with second-or third-degree atrioventricular block.”

In a memorandum for Regional Administrators from former Director Ruth McCully [2], of OSHA’s Directorate of Science, Technology and Medicine,

“Workers should be advised of the signs and symptoms of Lyme disease, as well as the primary and secondary preventive measures for decreasing the risk of Lyme disease transmission, acute illness, and chronic health effects. If recognized early, Lyme disease can be easily treated with antibiotic medication. However, if the disease goes unrecognized and untreated, chronic conditions may ensue, including varying degrees of permanent damage to the joints or the nervous system … “

“… In fact, the majority of infected persons do not recall being bitten by a tick … It is very important that the infection be diagnosed and treated with appropriate antimicrobial medication as early as possible because untreated Lyme disease may result in symptoms that are severe, chronic, and disabling. These disorders include chronic inflammatory arthritis, chronic muscle pain, heart disease, and/or neurological (brain and peripheral nerves) disorders. In addition, Lyme disease in a later stage is more difficult to diagnose, and treatment may be more prolonged and costly.”

VALNEVA VLA15 LYME VACCINE

Valneva, a biotech firm, plans to launch a Lyme vaccine. See studies:

—Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis—ClinicalTrials.gov Identifier: NCT03010228

—Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study—ClinicalTrials.gov Identifier: NCT03769194

In both study phases, the target is to enroll approximately 10 percent or more of subjects that are baseline seropositive for Borrelia burgdorferi sensu latu (Lyme).

Valneva announced in an October 2018 article that the:

“Vaccination with OspA was already proven to work in the 1990s” —Valneva is referring to the LYMErix vaccine.

“The safety profile is expected to be similar to other vaccines using the same technology that have been approved for active immunization in adults and children.”

“European Medicines Agency (EMA) provided positive feedback on the Company’s general development approach for its Lyme disease vaccine candidate, VLA15 [and] is largely aligned with previous discussions with the US Food and Drug Administration (FDA) on the strategy for the VLA15 development”

“It is planned to include both study participants that have previously been exposed to Lyme as well as study participants that have not experienced previous infection.”

“Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. Phase 2 is underway and may include 800 subjects at more than 10 study sites in Lyme endemic areas in the U.S. and Europe.”

QUESTIONS

  1. Has the LYMErix vaccine health risk been disclosed to these Valneva Lyme vaccine study subjects?
  2. How will VLA15 accommodate the health risks particular to children?
  3. Will Valneva provide access to all Lyme treatment options from guidelines that meet international standards to those subjects —including children— who develop Lyme infection from the VLA15 studies? Including the: 10 percent or more persons recruited who are seropositive for Lyme infection?  Persons recruited who are seronegative for Lyme infection?
  4. How will the Tick Borne Diseases Working Group 2020 Report to Congress influence the VLA15 Lyme vaccine safety concerns—particularly those regarding children?
  5. Will the Tick Borne Diseases Working Group 2020 Report to Congress promote VLA15, which is a commercial venture by Valneva?
  6. Does the US federal government —e.g. HHS, CDC, NIH, DOD, or any of their employees— own patents related to VLA15?
  7. Do any members of the Tick Borne Diseases Working Group —and/or its Subcommittees— have conflicts of interests related to VLA15?
  8. Other questions? Other concerns?

Faithfully,

Jenna

Jenna Luché-Thayer. 30+ years working globally on the rights of the marginalized. Former Senior Advisor to the United Nations and the US Government. Director, Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes. Founder, Global Network on Institutional Discrimination, Inc. —Holding institutions accountable for political and scientific solutions. Email jennaluche@gmail.com

__________________

For more:  https://madisonarealymesupportgroup.com/2018/06/06/valneva-seeking-partner-for-350m-lyme-disease-vaccine-effort-prepping-for-phase-2/

https://madisonarealymesupportgroup.com/2017/01/26/lyme-vaccine-to-be-tested-on-humans/

https://madisonarealymesupportgroup.com/2018/07/10/new-effort-for-lyme-disease-vaccine-draws-early-fire/

https://madisonarealymesupportgroup.com/2018/07/01/lyme-vaccine-fail-safety-ignored/

https://madisonarealymesupportgroup.com/2018/06/07/the-lyme-vaccine-russian-roulette/

https://madisonarealymesupportgroup.com/2018/07/22/why-we-care-so-strongly-about-a-potential-lyme-vaccine/

This vaccine should draw early fire, middle fire, and late fire.  The problems with it are endless.

 

Category:

Activism, Lyme, vaccines

My Kid is Not Crazy – Study Shows 1/3 Kids With PANS Have Hallucinations

https://player.vimeo.com/video/212986148 <p><a href=”https://vimeo.com/212986148″>My Kid is Not Crazy: A search for hope in the face of misdiagnosis</a> from <a href=”https://vimeo.com/user31889281″>4 The Kids Films</a> on <a href=”https://vimeo.com”>Vimeo</a&gt;.</p>”>

Trailer here.

A doctor battles to save children with disabling mental illness.

Could the answer be simpler than everyone thinks?

Nine-year-old Kathryn was a normal, healthy child. She was a star student, athlete and dancer. In a matter of days, she would become totally dysfunctional. Kathryn had alarming rapid-onset OCD refusing to eat or drink. She had tremendous separation anxiety and would become panicked if her parents were not in sight. She had trouble sleeping and showed signs of age regression in vocabulary and handwriting.

How did this happen?

More than 30 years ago, a doctor discovered that an undiagnosed strep infection was the cause of one child’s disabling illness. More and more evidence was found: Strep was linked to symptoms normally chalked up to psychiatric illness. Modern medicine has been very slow to adopt this new idea.

“My Kid is Not Crazy,” a film by Tim Sorel, tracks the journey of six children and their families as they become tangled in the nightmare of a medical system that lacks the compassion and knowledge to treat these children.

MY KID IS NOT CRAZY IS THE CINEMATIC, PEDIATRIC EQUIVALENT OF BRAIN ON FIRE-MEETS-INFECTIOUS MADNESS. A FILM THAT WILL CHANGE THE WAY WE LOOK AT MENTAL ILLNESS FOREVER. -CHICAGO NOW

Rent on Vimeo for $3.99

_______________

https://www.sciencedirect.com/science/article/pii/S0022395618307027

This 2018 study shows that over 1/3 of kids with PANS have hallucinations and are more impaired than those without psychotic symptoms.  The authors admonish clinicians to screen for abrupt-onset of a symptom cluster including OCD and/or food refusal, with neuropsychiatric symptoms (enuresis, handwriting changes, tics, hyperactivity, sleep disorder). 

_______________

**Comment**

I post articles and videos on PANS/PANDAS, Autism, and other illnesses with an autoimmune label due to the fact that tick borne illness can be a part of this picture and a trigger which starts the downward cascade.

Please educate your loved ones about this potential as children are losing their childhoods to unbelievable misdiagnosis and suffering.

Vaccines can also be triggers:  https://madisonarealymesupportgroup.com/2017/09/21/aluminum-flawed-assumptions-fueling-autoimmune-disease-and-lyme/

https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/  He has also successfully treated a number of young women who fell ill after their HPV vaccination, which seems to have stimulated a latent Lyme infection to reactivate.

https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/

Asymptomatic girls after receiving Gardasil activated dormant Bartonella which was confirmed by testing.

https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/  Data suggests that 6% of the U.S. population is harboring a retrovirus in their bodies that can develop into an acquired immune deficiency. This is not the well-known AIDS caused by HIV, but Acquired Immune Deficiency Syndrome (AIDS) associated with other retroviruses.  These non-HIV retroviruses were unintentionally introduced into humans over the past 75 years.  It began with trials of polio vaccines and yellow fever vaccines given in the early 1930s. This is when the first recorded cases of Chronic Fatigue Syndrome and autism appeared. It involved the use of laboratory mice to prepare vaccines for human use. [1]

More on PANS:  https://madisonarealymesupportgroup.com/2018/10/10/pans-pandas-awareness/

https://madisonarealymesupportgroup.com/2017/06/30/child-with-lymemsidspans-told-by-doctors-she-made-it-all-up/

https://madisonarealymesupportgroup.com/2018/08/01/the-3-pans-myths-that-are-ruining-lives/

 

 

 

 

 

 

Category:

Activism, Lyme, PANS, Psychological Aspects, vaccines

For Health Officials & School Boards: Asymptomatic Measles Infection is Real

https://jameslyonsweiler.com/2018/12/15/for-health-officials-and-school-boards-asymptomatic-measles-infection-is-real/

For Health Officials & School Boards:  Asymptomatic Measles Infection is Real

By James Lyons Weiler

December, 15, 2018

There was a time when it was openly recognized that vaccinated individuals could become infected with wild-type measles. These infections are called subclinical infections (aka asymptomatic infections). We don’t talk about that very much anymore. In fact, two days ago I had a conference call with a high-ranking health official at the NYC Health Commission who claimed that it does not happen – specifically, that official stated that subclinical infections do not occur.

Given that this person is so obviously misinformed, I thought I would provide a literature resource for those who might not realize this reality: vaccinated individuals can, and have always, been known to be able to be infected with wild-type measles virus. Since this is true, the rare non-vaccinated child is not, in a highly vaccinated population, to be the primary source of new transmissions of measles. Instead, the vaccinated individuals with subclinical infections may be driving new infections in schools. It is therefore illogical, and quite unfair, to blame unvaccinated individuals when infected asymptomatic individuals can go to school unabated.

If we are to have public health policies based on science, this science must be given due consideration; otherwise, we would have public health policies based on something other than science. In reality, in highly vaccinated populations, measles can spread from a majority of vaccinated, to a minority of unvaccinated people, causing overt disease. In other words, the unvaccinated merely expose the circulating measles virus, and any child with a compromised immune system may be exposed even in a fully vaccinated population.

Not all full texts are freely available online, but some are. Here are some relevant examples from the primary scientific literature.

Nonclassic measles infections in an immune population exposed to measles during a college bus trip. Helfand RF https://www.ncbi.nlm.nih.gov/pubmed/?term=9829639

“Mild or asymptomatic measles infections are probably very common among measles-immune persons exposed to measles cases and may be the most common manifestation of measles during outbreaks in highly immune populations.”

Current status of measles in Japan. Nakayama T, Zhou J, Fujino M. https://www.ncbi.nlm.nih.gov/pubmed/12673398

“Measles infection is considered to provide lifelong immunity after an infection and, thus, live measles vaccines also induce longterm immunity. But long-term immunity is now considered to be an effect of natural boosts via subclinical reinfection. Subclinical infection has been demonstrated by sero-conversion, but the isolation or detection of the measles virus genome was rarely demonstrated”…

“Potential impediments to eradication include: (1) a lack of political will in some industrialized countries, (2) transmission among adults, (3) increasing urbanization and population density, (4) HIV epidemics, (5) waning immunity and the possibility of transmission from subclinical cases, and (6) risk of unsafe injection.”

Protective titres of measles neutralising antibody. Lee MS et al. https://www.ncbi.nlm.nih.gov/pubmed/11074481

“…only 1 vaccinee with HI titre #31 mIU/ml experienced typical measles symptoms and 13 vaccinees with HI titres #31 mIU/ml experienced subclinical infection.”

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Whittle HC et al. https://www.ncbi.nlm.nih.gov/pubmed/?term=10023894

“Subclinical measles occurred in 39 (45%) of 86 vaccinated children who were exposed to measles and in four (25%) of 16 unvaccinated children…”

Detection of measles virus genome in lymphocytes from asymptomatic healthy children. Sonoda S, Nakayama T. https://www.ncbi.nlm.nih.gov/pubmed/11536248

“Serological confirmation of subclinical re-infection was obtained by pre-exposure in household-exposed parents who developed asymptomatic secondary immune responseswith a concomitant increase in specific IgG neutralizing test antibodies and haemagglutination inhibition titres…Subclinical infection was confirmed in adulthood.”

“In Japan, measles virus has been circulating and asymptomatic infection has occurred frequently…”

The Clinical Significance of Measles: A Review Walter A. Orenstein Robert T. Perry Neal A. Halsey https://academic.oup.com/jid/article/189/Supplement_1/S4/823958

“People with inapparent subclinical measles virus infections are not known to transmit measles virus to household contacts.”

Detection of measles virus genome in bone-marrow aspirates from adults. Sonoda S, Kitahara M, Nakayama T. http://www.microbiologyresearch.org/docserver/fulltext/jgv/83/10/0832485a.pdf

Waning immunity and subclinical measles infections in England. Glass K, Grenfell BT. https://www.ncbi.nlm.nih.gov/pubmed/15364464

“A comparison of these cases … shows us that adding subclinical infections to the model also increases the number of clinical cases, as the subclinical infections increase the levels of circulating virus. This feature is more pronounced … because {when) vaccination
levels are higher … subclinical cases make up a greater proportion of the total cases.”

Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Pedersen IR https://www.ncbi.nlm.nih.gov/pubmed/2815970

“measles can spread from a majority of vaccinated, to a minority of unvaccinated people, causing overt disease.”

Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. Vardas E, Kreis S https://www.ncbi.nlm.nih.gov/pubmed/10443793

Risk analysis for measles reintroduction post global certification of eradication. Dr Ray Sanders. https://www.who.int/immunization/sage/7._Measles_post_eradication_risk_analysis.pdf

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)02364-2/fulltext

Measles eradication: is it in our future? Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1446359/

The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines?https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905323/

Modeling the Impact of Subclinical Measles Transmission in Vaccinated Populations with Waning Immunity  Mossong, J et al. https://watermark.silverchair.com/150-11-1238.pdf

“In view of eradication, it is therefore important to investigate whether current vaccines perform well enough to prevent persistence of wild virus in highly or even fully vaccinated populations.”

jameslyonsweiler
Dr. Lyons-Weiler is a research scientist and author of three books, the latest of which is “The Environmental and Genetic Causes of Autism”. He is available for speaking engagements and book signing events at your location. To contact, follow on twitter @lifebiomedguru, email ebolapromo@gmail.com, and connect via LinkedIn https://www.linkedin.com/in/jameslyonsweiler

 

Category:

Activism, vaccines